Piperazine compound and application thereof

A compound and selected technology, applied in organic chemistry, drug combination, medical preparations containing active ingredients, etc., can solve problems affecting the body's cognition, memory, acetylcholine deficiency, and failure of nerve signal transmission

Active Publication Date: 2014-04-02
JIANGSU SIMCERE PHARMA
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, because acetylcholinesterase can catalyze the cleavage reaction of acetylcholine, it will lead to the loss of acetylcholine and the failure of nerve signal transmission, thus affecting the body's cognition, memory and other functions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Piperazine compound and application thereof
  • Piperazine compound and application thereof
  • Piperazine compound and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Embodiment 1 prepares compound 1 provided by the invention

[0051] The preparation process is as follows:

[0052]

[0053] At room temperature, 62.7g of anhydrous piperazine about 72.9mmol in 100ml of toluene, add 5.7g of K 2 CO 3 About 41.8mmol of solid powder and about 20.9mmol of 3.1g of catalytic NaI were heated and stirred until the solid was dissolved, and about 20.9mmol of 5.0g of 4,4'-difluorodiphenylchloromethane was added, and the system was heated and refluxed for 8 hours. The reaction was detected by TLC and the reaction was complete After cooling, the reaction system was filtered, and the filtrate was concentrated to obtain an oil, which was directly purified by silica gel column chromatography, using petroleum ether: ethyl acetate = 1: 1 ~ 1: 2 ~ pure ethyl acetate (1% triethylamine) Gradient elution to obtain the oily product S 1 4.87g, yield 81.9%. ESI-MS[M+H] + =289.1

[0054]Weigh 10.0g of p-hydroxyacetophenone about 7.4mmol, 8.9g of N-meth...

Embodiment 2

[0059] Embodiment 2 prepares compound 2 provided by the invention

[0060] The preparation process is as follows

[0061]

[0062] Put 8.6g of anhydrous piperazine about 100mmol in 100ml of acetonitrile, add K 2 CO 3 Solid powder 13.8g is about 50mmol and catalytic amount NaI 1.5g is about 10mmol, heat and stir to dissolve the solid, add about 12.3g of diphenyl bromide about 50mmol, the system is heated and refluxed for 8h, TLC detects the reaction, after the reaction is complete, cool , filter the reaction system, and concentrate the filtrate to obtain an oil, which is directly purified by silica gel column chromatography, using petroleum ether: ethyl acetate = 1: 1 ~ 1: 2 (1% triethylamine), pure ethyl acetate (1% Triethylamine) gradient elution, obtain oil product S 2 8.17g, yield 64.8%. ESI-MS[M+H] + =253.2

[0063] Put 110mg S2 about 0.43mmol and 100mg S6 about 0.41mmol into the reaction bottle, add 130mg K 2 CO 3 The powder is about 0.94mmol and 15ml of aceto...

Embodiment 3

[0065] Embodiment 3 prepares compound 3 provided by the invention

[0066] The preparation process is as follows:

[0067]

[0068] Get 8.0g of 3-hydroxyacetophenone to be about 58.8mmol, 7.2g of N-methyl-N-ethylformyl chloride to be about 59.5mmol and K 2 CO 3 Add 16.5g of solid powder (about 122.2mmol) into the system, and add 150ml of acetone, reflux reaction, TLC detection After the reaction is completed, cool, filter the reaction solution, condense the filtrate and evaporate to dryness to obtain the oil S 6 13.3 g, yield 87.5%. ESI-MS[M+H] + =222.1

[0069] Will S 6 13.3g about 60.2mmol was dissolved in 150ml of methanol, slowly added NaBH under ice bath 4 4.1g is about 108.5mmol. There are bubbles in the system. Warm up to room temperature and stir overnight. TLC detects the reaction. After the reaction is complete, evaporate the reaction solution, add distilled water, and extract with ethyl acetate. The organic layer is washed with saturated saline. The organ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a piperazine compound and application of the piperazine compound served as a calcium channel blocker or / and an acetyl cholinesterase inhibitor.

Description

technical field [0001] The invention relates to the field of chemical synthesis, in particular to piperazine compounds and their application as calcium channel blockers or / and acetylcholinesterase inhibitors. Background technique [0002] Alzheimer's disease is a degenerative disease of the central nervous system characterized by chronic, progressive cognitive impairment and memory impairment. The main pathological features are senile plaques, neurofibrillary tangles and neuron loss, which seriously affects patients. Cognition, memory, language function and personal life ability and emotional personality. At present, the more accepted pathology of Alzheimer's disease in the world is the "cholinergic deficiency theory". The theory is that the loss of the neurotransmitter choline acetate in the patient's brain is the key cause of Alzheimer's disease. [0003] Cholinesterase is a key enzyme in biological nerve transmission. In cholinergic synapses, this enzyme can degrade ace...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D295/096C07D295/13C07D217/14A61K31/495A61K31/496A61P3/14A61P9/00A61P9/10A61P25/28
Inventor 陈荣俞森冯林董情理
Owner JIANGSU SIMCERE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap